OGI
Organigram Global, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$1.05
−1.87%Next report
Analyst consensus
- Next report date
- Dec 15, 2026
- EPS estimate
- $0.02
- Revenue estimate
- $86.2M
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- $0.55
- EPS estimate
- -$0.01
- Revenue actual
- $74.5M
- Revenue estimate
- $68.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +872.5%
- Revenue beats (12Q)
- 3
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.01 | $0.55 | Beat 5590.00% | $74.5M |
| May 12, 2026 | -$0.01 | -$0.01 | In line | $43.0M |
| Dec 16, 2025 | -$0.01 | -$0.20 | Miss -1900.00% | $57.4M |
| Aug 13, 2025 | -$0.01 | -$0.03 | Miss -200.00% | $52.0M |
| Feb 11, 2025 | -$0.03 | -$0.05 | Miss -66.67% | $29.7M |
| Dec 18, 2024 | -$0.03 | -$0.04 | Miss -33.33% | $33.1M |
| Feb 13, 2024 | -$0.10 | -$0.14 | Miss -40.00% | $27.4M |
| Dec 19, 2023 | -$0.14 | -$0.04 | Beat 71.43% | $34.0M |
| Jul 13, 2023 | -$0.05 | -$0.15 | Miss -200.00% | $24.3M |
| Apr 11, 2023 | -$0.07 | -$0.08 | Miss -19.99% | $29.0M |
| Jan 12, 2023 | -$0.01 | -$0.04 | Miss -184.90% | $32.1M |
| Nov 28, 2022 | -$0.08 | -$0.08 | In line | $34.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 15, 2026